Enhance your nephrology practice with CME and tools focused on kidney medicine.
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
Pauline A. Swift, PhD
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Potassium Binders to Optimize GDMT Therapy in HFrEF
Ellie Kelepouris, MD, FACP, FAHA
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Decoding IgA Nephropathy: From Suspicion to Solution
Chee Kay Cheung, MBChB, MRCP, PhD
An De Vriese, MD, PhD
Jörg Latus, MD
The Evolving Role of Biomarkers in IgAN
Translating Evidence into IgAN Care
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
The Future of IgAN Care
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Itching for Answers: Holistic CKD-aP Care
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
When Itching Hurts: Quality of Life Disruption in CKD-aP
Gabapentinoids: Safety Considerations and Downstream Outcomes
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.